Literature DB >> 30789289

Testosterone Levels in Women: Implications for Fatty Liver and Beyond.

Monika Sarkar1.   

Abstract

Entities:  

Year:  2019        PMID: 30789289      PMCID: PMC6709945          DOI: 10.1089/jwh.2019.7661

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


× No keyword cloud information.
  16 in total

Review 1.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

Review 2.  Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis.

Authors:  Veeravich Jaruvongvanich; Anawin Sanguankeo; Tanawan Riangwiwat; Sikarin Upala
Journal:  Ann Hepatol       Date:  2017 May - Jun       Impact factor: 2.400

3.  Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.

Authors:  Monika Sarkar; Melissa Wellons; Marcelle I Cedars; Lisa VanWagner; Erica P Gunderson; Veeral Ajmera; Laura Torchen; David Siscovick; J Jeffrey Carr; James G Terry; Mary Rinella; Cora E Lewis; Norah Terrault
Journal:  Am J Gastroenterol       Date:  2017-03-14       Impact factor: 10.864

4.  Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis.

Authors:  Mariana Lazo; Irfan Zeb; Khurram Nasir; Russell P Tracy; Matthew J Budoff; Pamela Ouyang; Dhananjay Vaidya
Journal:  Clin Gastroenterol Hepatol       Date:  2015-01-13       Impact factor: 11.382

5.  Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.

Authors:  Stergios A Polyzos; Jannis Kountouras; Christos S Mantzoros; Vaia Polymerou; Panagiotis Katsinelos
Journal:  Diabetes Obes Metab       Date:  2017-07-10       Impact factor: 6.577

Review 6.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Eric L Ding; Yiqing Song; Vasanti S Malik; Simin Liu
Journal:  JAMA       Date:  2006-03-15       Impact factor: 56.272

7.  Effects of spironolactone on glucose transport and interleukin-6 secretion in adipose cells of women.

Authors:  A Corbould
Journal:  Horm Metab Res       Date:  2007-12       Impact factor: 2.936

Review 8.  Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?

Authors:  A Corbould
Journal:  Diabetes Metab Res Rev       Date:  2008-10       Impact factor: 4.876

9.  Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism.

Authors:  Shigehiro Karashima; Takashi Yoneda; Mitsuhiro Kometani; Masashi Ohe; Shunsuke Mori; Toshitaka Sawamura; Kenji Furukawa; Takashi Seta; Masakazu Yamagishi; Yoshiyu Takeda
Journal:  Hypertens Res       Date:  2015-11-26       Impact factor: 3.872

10.  Serum free fatty acid levels in PCOS patients treated with glucophage, magnesium oxide and spironolactone.

Authors:  Ozgul Muneyyirci-Delale; Julie Kaplan; Ibrahim Joulak; Lianfu Yang; Hans Von Gizycki; Vijaya L Nacharaju
Journal:  Gynecol Endocrinol       Date:  2013-03-06       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.